Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001063573 | SCV001228426 | pathogenic | Aortic valve disease 2 | 2020-01-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys24Alafs*42) in the TBX5 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TBX5 are known to be pathogenic (PMID: 16183809, 16917909). This variant has not been reported in the literature in individuals with TBX5-related conditions. This variant is not present in population databases (ExAC no frequency). |